EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bilateral Enlarged Vestibular Aqueduct: Auditory, Genetic and Radiological Characterization, and Benefits of Cochlear Implants

Augustin Vigouroux, Benjamin Glemain, Renato Torres, Laurence Jonard, Natalie Loundon, Evelyne Ferrary, Isabelle Mosnier, Hannah Daoudi, Sandrine Marlin, Ghizlene Lahlou iD

Otolaryngology–Head and Neck Surgery · 2025

DOI: 10.1002/ohn.1375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2025. Verfasst von Augustin Vigouroux und 9 weiteren Autor:innen. Beteiligte Einrichtung: APHP, Sorbonne Université, GHU Pitié-Salpêtrière, Service d'ORL et de chirurgie cervico-faciale, UF Implants Auditifs, Paris, France. Hauptthemen laut MEDLINE: Vestibular Aqueduct, Cochlear Implantation, Hearing Loss, Sensorineural, Cochlear Implants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondation pour l'Audition.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The study aimed to describe the auditory phenotype of patients with bilateral enlarged vestibular aqueduct, including benefits of cochlear implantation, and to look for genotype‐phenotype correlation. Study Design Retrospective single‐center study.

Setting

Tertiary adult reference center.

Methods

Fifty‐eight patients were included. Evolution of pure tone and speech audiometry was analyzed. Cochlear size, vestibular aqueduct width, and endolymphatic duct and sac volume were assessed on both computed tomography scan and magnetic resonance imaging. Genetic explorations were documented, and genotype‐phenotype correlations were explored. Outcomes after cochlear implant (CI) were analyzed.

Results

Hearing loss was diagnosed at 4 ± 4.0 years, being initially severe‐to‐profound in 74% of the ears. Sudden sensorineural hearing loss concerned 54% of patients. Both vestibular aqueduct and endolymphatic sac showed symmetric measurements ( P < .001). Patients with SLC26A4 biallelic alterations (n = 22) had more associated thyroid disorders (14/22 vs 3/31, P < .001), earlier (2 ± 1.6 years old [yo] vs 5 ± 4.5 yo, P < .001) and lower age‐adjusted pure‐tone average ( P < .001, two‐way analysis of variance), and greater endolymphatic sac volume (369 ± 118.1 mm 3 vs 194 ± 208.7 mm 3 , P = .042), compared with patients with unconclusive genetic results. Consequently, more patients with SLC26A4 biallelic alterations received a CI (19/22 vs 17/31, P = .015) and at an earlier age (18 ± 12.5 yo vs 34 ± 18.9 yo, P = .009). Finally, 12 months after cochlear implantation, speech intelligibility for words improved from 23% ± 27.6% to 61% ± 34.7% in silence ( P = .0012), and from 30% ± 31.3% to 87% ± 10.6% in noisy conditions.

Conclusion

The auditory phenotype of patients with bilateral enlarged vestibular aqueduct is variable but seems to be more severe in case of biallelic alterations of SLC26A4 . However, cochlear implantation benefits to these patients, regardless of genotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vestibular AqueductCochlear ImplantationHearing Loss, SensorineuralCochlear ImplantsHumansRetrospective StudiesMaleFemaleChild, PreschoolAdultChildMagnetic Resonance ImagingTomography, X-Ray ComputedAdolescentSulfate TransportersPhenotypeAudiometry, Pure-ToneGenetic Association StudiesYoung AdultMiddle Aged

Stichwörter der Autor:innen

cochlear implantenlarged vestibular aqueductgeneticshearing loss

Substanzen

SLC26A4 protein, humanSulfate Transporters

Autor:innen und Institutionen

  • APHP, Sorbonne Université, GHU Pitié-Salpêtrière, Service d'ORL et de chirurgie cervico-faciale, UF Implants Auditifs, Paris, France.
  • Sorbonne Université, Inserm, Institut Pierre-Louis d'Épidémiologie et de Santé Publique, Paris, France.
  • APHP, Sorbonne Université, Hôpital Saint-Antoine, Département de Santé Publique, Paris, France.
  • Université Paris Cité, Institut Pasteur, AP-HP, Inserm, Fondation Pour l'Audition, Institut de l'Audition, IHU reConnect, Technology and Gene Therapy for Deafness, Paris, France.
  • Centre Hospitalier Sud Francilien, service ORL et chirurgie maxillo-faciale, Corbeil-Essonnes, France.
  • APHP Université Paris Cité, Hôpital Necker-Enfants Malades, Centre de références «Surdités Génétiques», Fédération de Génétique, Centre de Recherche en Audiologie (CREA), Paris, France.

ORCID-Profile: Ghizlene Lahlou

Förderung

  • Fondation pour l'Audition

Zitieren

APA

Vigouroux, A., Glemain, B., Torres, R., Jonard, L., Loundon, N., Ferrary, E., Mosnier, I., Daoudi, H., Marlin, S., & Lahlou, G. (2025). Bilateral Enlarged Vestibular Aqueduct: Auditory, Genetic and Radiological Characterization, and Benefits of Cochlear Implants. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1375

Vancouver

Vigouroux A, Glemain B, Torres R, Jonard L, Loundon N, Ferrary E, et al. Bilateral Enlarged Vestibular Aqueduct: Auditory, Genetic and Radiological Characterization, and Benefits of Cochlear Implants. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1375

BibTeX
@article{Vigouroux2025,
  author = {Vigouroux, Augustin and Glemain, Benjamin and Torres, Renato and Jonard, Laurence and Loundon, Natalie and Ferrary, Evelyne and Mosnier, Isabelle and Daoudi, Hannah and Marlin, Sandrine and Lahlou, Ghizlene},
  title = {Bilateral Enlarged Vestibular Aqueduct: Auditory, Genetic and Radiological Characterization, and Benefits of Cochlear Implants},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2025},
  doi = {10.1002/ohn.1375}
}
Kostenlos starten →